Wan B, Hu J, Luo Y, Han Y, Zhang Y, Huang Q
Front Pharmacol. 2025; 16:1523014.
PMID: 39931690
PMC: 11808154.
DOI: 10.3389/fphar.2025.1523014.
Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R
Circ Res. 2024; 136(1):26-40.
PMID: 39629565
PMC: 11692786.
DOI: 10.1161/CIRCRESAHA.124.325017.
Parichatikanond W, Duangrat R, Kurose H, Mangmool S
Cells. 2024; 13(20.
PMID: 39451192
PMC: 11506672.
DOI: 10.3390/cells13201674.
Li X, Liu Y, Tang Y, Xia Z
Front Immunol. 2024; 15:1474688.
PMID: 39386212
PMC: 11461261.
DOI: 10.3389/fimmu.2024.1474688.
Cao X, Wu X, Zhang Y, Qian X, Sun W, Zhao Y
Bioact Mater. 2024; 42:449-477.
PMID: 39308549
PMC: 11415838.
DOI: 10.1016/j.bioactmat.2024.09.001.
Dual Blockade of TGF-β Receptor and Endothelin Receptor Synergistically Inhibits Angiotensin II-Induced Myofibroblast Differentiation: Role of ATR/G-Mediated TGF-β1 and ET-1 Signaling.
Duangrat R, Parichatikanond W, Mangmool S
Int J Mol Sci. 2023; 24(8).
PMID: 37108136
PMC: 10138810.
DOI: 10.3390/ijms24086972.
Endothelin-1 Induces Cell Proliferation and Myofibroblast Differentiation through the ETR/G/ERK Signaling Pathway in Human Cardiac Fibroblasts.
Duangrat R, Parichatikanond W, Likitnukul S, Mangmool S
Int J Mol Sci. 2023; 24(5).
PMID: 36901906
PMC: 10002923.
DOI: 10.3390/ijms24054475.
Ubiquitin like protein FAT10 repressed cardiac fibrosis after myocardial ischemic via mediating degradation of Smad3 dependent on FAT10-proteasome system.
Chen C, Li X, Zhou T, Su Y, Yu B, Jin J
Int J Biol Sci. 2023; 19(3):881-896.
PMID: 36778114
PMC: 9910007.
DOI: 10.7150/ijbs.77677.
GRK5-mediated inflammation and fibrosis exert cardioprotective effects during the acute phase of myocardial infarction.
Nagasaka A, Terawaki T, Noda M, Takashima M, Fujino M, Yamauchi Y
FEBS Open Bio. 2023; 13(2):380-391.
PMID: 36633120
PMC: 9900089.
DOI: 10.1002/2211-5463.13551.
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity.
Shi L, Du X, Zuo B, Hu J, Cao W
Evid Based Complement Alternat Med. 2022; 2022:2894659.
PMID: 35911163
PMC: 9328975.
DOI: 10.1155/2022/2894659.
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis.
Qin R, Zhao Q, Han B, Zhu H, Peng C, Zhan G
Front Pharmacol. 2022; 13:845892.
PMID: 35250597
PMC: 8888875.
DOI: 10.3389/fphar.2022.845892.
Angiotensin II-Treated Cardiac Myocytes Regulate M1 Macrophage Polarization via Transferring Exosomal PVT1.
Cao F, Li Z, Ding W, Yan L, Zhao Q
J Immunol Res. 2021; 2021:1994328.
PMID: 34514000
PMC: 8427676.
DOI: 10.1155/2021/1994328.
Cardiac Fibrosis and Fibroblasts.
Kurose H
Cells. 2021; 10(7).
PMID: 34359886
PMC: 8306806.
DOI: 10.3390/cells10071716.
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II-induced adverse cardiac remodeling in mice.
Lu W, Meng Z, Hernandez R, Zhou C
JCI Insight. 2021; 6(18).
PMID: 34324438
PMC: 8492299.
DOI: 10.1172/jci.insight.150161.
Long non-coding RNA XIST promotes the proliferation of cardiac fibroblasts and the accumulation of extracellular matrix by sponging microRNA-155-5p.
Zhang H, Ma J, Liu F, Zhang J
Exp Ther Med. 2021; 21(5):477.
PMID: 33767772
PMC: 7976373.
DOI: 10.3892/etm.2021.9908.
Eplerenone Attenuates Fibrosis in the Contralateral Kidney of UUO Rats by Preventing Macrophage-to-Myofibroblast Transition.
Xiong Y, Chang Y, Hao J, Zhang C, Yang F, Wang Z
Front Pharmacol. 2021; 12:620433.
PMID: 33716747
PMC: 7943730.
DOI: 10.3389/fphar.2021.620433.
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways.
Procopio M, Lauro R, Nasso C, Carerj S, Squadrito F, Bitto A
Biomedicines. 2021; 9(2).
PMID: 33670488
PMC: 7922652.
DOI: 10.3390/biomedicines9020204.
Uncovering potential differentially expressed miRNAs and targeted mRNAs in myocardial infarction based on integrating analysis.
Wang S, Cao N
Mol Med Rep. 2020; 22(5):4383-4395.
PMID: 33000230
PMC: 7533449.
DOI: 10.3892/mmr.2020.11517.
Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin.
Eid R, Khalil M, Alkhateeb M, Eleawa S, Ahmed Zaki M, El-Kott A
Cardiovasc Drugs Ther. 2020; 35(6):1095-1110.
PMID: 32474680
DOI: 10.1007/s10557-020-07006-9.
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling.
Parichatikanond W, Luangmonkong T, Mangmool S, Kurose H
Front Cardiovasc Med. 2020; 7:34.
PMID: 32211422
PMC: 7075814.
DOI: 10.3389/fcvm.2020.00034.